edited drugs for repro_endo - Sheet1 Flashcards
(130 cards)
amiloride
blocks Na channels -> decr MC effects in hyperaldosteronism *weaker effect than spirolactone
spironolactone: action, use and dosage (3 doses for 6 diseases)
antagonist at MC receptors (also androgen and progesterone receptors); 25-50 mg daily as K sparing diuretic for HTN and edematous states (CHF, cirrhosis, nephoris); 400 mg daily in primary hyperaldosteronism; 200 mg daily in PCOS (used off label for anti-androgen effects)
spironolactone side effects (4)
hyperkalemia, volume depletion, men: gynecomastia, impaired libido, impotence; women: mest. irregularities
eplerenone
highly selective (and expensive) MC antagonist (not androgens nor progesterone)
contraindications for spironolactone (3)
renal impairment, hyperkalemia, pregnancy
metyrapone
blocks 11-beta enzyme that converts 11-DOC -> cortisol; doesn’t interfere with aldosterone or androgen production (dx adrenal insufficiency as primary or central by seeing relative ACTH/11-DOC levels)
hydrocortisone dosing
physiological: 20-30 mg/day in the am; stress: 50 mg every 6-8 hrs; acute: 100 mg IV/IM every 6-8 hrs (don’t need MC replacement b/c hydrocortisone works as MC above 100 mg)
dex dosing
physiological: .5 mg daily; stress: 2 mg every 12 hrs; acute: 4 mg IV/IM
ketoconazole
non-specific inhibitor of cortisol synthesis (inhibits at 3 steps)
cabergoline
DA agonist used to tx somatotroph adenoma -> paradoxical effect
octreotide
STT analog used to tx somatotroph or thyrotroph adenoma
pegvisomant
GH anatagonist used to tx somatotroph adenoma -> binds only 1/2 receptor and thus blocks it
metformin: action, MOA, effect, metab, adverse effects (4), benefits (3), contraindications (5), misc (1)
prevents gluconeogenesis (and poss glycogenolysis); phosphorylation (activation) of AMPK; improves fasting glucose (little effect on postprandial); not metabolized, renally excreted unchanged (can accum. if renal insuff); adverse: anorexia, nausea, diarrhea, lactic acidosis; benefits: immed onset (altho need to titrate slowly to avoid GI effects), no hypoglycemia, weight neutral (poss loss) -> first drug of choice; contraindications: prone to acidosis, hypoxic states, renal failure, cardiac ischemia, T1DM; need insulin to work!
TZDs: action, MOA, effect, duration/onset, contraindications (3), adverse effects (3), benefits (3)
incr. periph tissue sensitivity to insulin; binds to nuclear PPAR-gamma receptor (incr. GLUT4 transcription); lowers fasting and post-meal glucose; slow onset of action (fasting gluc begins to decr w/in 5-7 days but doesn’t completely decline until 2-3 mons); contraindications: liver disease, heart failure, renal insuff.; side effects: weight gain (improved glyc. control and incr water due to Na reabs), hepatocellular injury, incr LDL; benefits: reduces TGs, raises HDL, no hypoglycemia
secretagogues: types (2), differences
sulfonylurea and meglitinides; both bind the beta cell ATP-dep K channel but meglitinide binds more quickly and dissociates more quickly (shorter duration -> 3-4 hrs vs 12-24)
sulfonylurea: action, MOA, duration, effect, metab, contraindications (3), adverse effects (3)
secretagogue; binds to sulfonyl receptor in beta cell causing depolarization of ATP-dependent K channels; 12-24 hrs duration; effect on fasting glucose; metab: excreted via kidney w/ active metabs (careful w/ renal probs); contraind: T1DM, DKA, sulfa allergy; adverse effects: hypoglycemia, weight gain, hunger
meglitinides: action, MOA, duration and onset, metab, contraindications (4), adverse effects (2), aka
secretagogue; binds to sulfonyl receptor in beta cell causing depolarization of ATP-dependent K channels; 3-4 hrs duration w/ fast onset (give w/ every meal -> hard for compliance); metab: hepatic (P450) w/ most metabs excreted GI; contraind: T1DM, liver failure, DKA, sulfa allergy; adverse effects: low glucose 2-4 hrs after meal, weight gain; aka glinides
alpha-glucoside inhibitors: MOA, effects, side effects (2), contraindications (1), metab
delay carbohydrate absorption (inhibits intestinal enzymes ability to break down sugars) and thus incr GLP-1; effects postprandial glucose only; side effects: flatulence, bloating -> titrate slowly to minimize; contraindications: GI disorders (esp IBD); metab: renally excreted unchanged
GLP-1 mimetic: names (2), comparison, contraindications (2), effect, metab, benefits (2), side effects (1)
exenatide (from Gila monster) and liraglutide; liraglutide is once daily injection b/c binds albumin vs. exenatide is twice daily (60 mins before each meal); avoid in pts with severe GI disease or on drugs that need rapid GI abs; effect on postprandial glucose; metab: renal after DPP-4 breakdown; benefit: weight loss, no hypoglycemia; side effects: GI
biguanides: names (1)
metformin
incretin enhancers: MOA, duration, effect, metab, contraind, adverse effects, benefits (2)
DPP-4 inhibitors; 80% inhib at 24 hrs (take 1 daily); immed effect on postprandial glucose; metab: renally excreted unchanged (dose adj for renal probs); contraindications: none; adverse effects: GI; benefits: weight neutral, no hypoglycemia
glimeperide: what is it, brand name
aka Amaryl, a sulfonyurea
bolus insulin types (3) and peak times
rapid: Aspart, Lipro (1 hr to peak); short-acting: regular (2-4 hrs to peak -> complexed w/ zinc)
basal insulin types (3) and dosing
intermediate: NPH (once or twice/day); long acting: glargine (once/day), detemir (once or twice/day)